Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-Cancer

BACKGROUND: Nowadays, PD-1/PD-L1 inhibitors are widely used to treat various malignant tumors. However, during the immunotherapy in a few patients, a flare-up of tumor growth occurred. This new pattern of progression is called hyperprogressive disease (HPD). Patients and Methods. The retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shiyun, Gou, Miaomiao, Yan, Huan, Fan, Mengjiao, Pan, Yuting, Fan, Runjia, Qian, Niansong, Dai, Guanghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241516/
https://www.ncbi.nlm.nih.gov/pubmed/34239621
http://dx.doi.org/10.1155/2021/6639366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241516/
https://www.ncbi.nlm.nih.gov/pubmed/34239621
http://dx.doi.org/10.1155/2021/6639366

Ejemplares similares